A therapeutic combination of drugs for the treatment of a liver cancer includes a crocin, or a pharmaceutically acceptable pro-drug thereof, and sorafenib. A method of treating, suppressing, or reducing the severity of a liver cancer in a subject, involves administering to the subject a first amount of sorafenib, and administering to the subject a second amount of a crocin or a pharmaceutically acceptable pro-drug thereof.